Concepedia

Sridharan Jayamohan

SJ

6

Publications

149

Citations

6

H-Index

2019

Active since

Affiliations

Mays Cancer Center at UT Health San Antonio(Current)

The University of Texas Health Science Center at San Antonio

South Texas Veterans Health Care System

Audie L. Murphy Memorial VA Hospital

Murphy Oil Corporation (United States)

Sridharan Jayamohan is an author at Mays Cancer Center at UT Health San Antonio specializing in medicine, radiation oncology, and cancer cell biology.

ORCID

Top concepts

Publications per year

2019–2024

6

Publications

6

Lysine-specific histone demethylase 1A (KDM1A/LSD1) inhibition attenuates DNA double-strand break repair and augments the efficacy of temozolomide in glioblastoma

Salvador Alejo, Bridgitte E. Palacios, Prabhakar Pitta Venkata et al. · Neuro-Oncology · 2023 · 43 citations · Full text

Dysregulation of miR-375/AEG-1 Axis by Human Papillomavirus 16/18-E6/E7 Promotes Cellular Proliferation, Migration, and Invasion in Cervical Cancer

Sridharan Jayamohan, Maheshkumar Kannan, Rajesh Kannan Moorthy et al. · Frontiers in Oncology · 2019 · 40 citations · Full text

RETRACTED: AEG-1/miR-221 Axis Cooperatively Regulates the Progression of Hepatocellular Carcinoma by Targeting PTEN/PI3K/AKT Signaling Pathway

Maheshkumar Kannan, Sridharan Jayamohan, Rajesh Moorthy et al. · International Journal of Molecular Sciences · 2019 · 20 citations · Full text

, , +16

Evidence for 2-Methoxyestradiol-Mediated Inhibition of Receptor Tyrosine Kinase RON in the Management of Prostate Cancer

Izhar Singh Batth, Shih‐Bo Huang, Michelle Villarreal et al. · International Journal of Molecular Sciences · 2021 · 17 citations · Full text

Pharmacological inhibition of KDM1A/LSD1 enhances estrogen receptor beta-mediated tumor suppression in ovarian cancer

Prabhakar Pitta Venkata, Sridharan Jayamohan, Yi He et al. · Cancer Letters · 2023 · 17 citations · Full text

, , +6

Rows per page

1–5 of 6